Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP522207.RAupVIWkC-nB1Iok47Mpc27YFx0ECW0WwSyAYbQxyN8k0130_assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP522207.RAupVIWkC-nB1Iok47Mpc27YFx0ECW0WwSyAYbQxyN8k0130_provenance.
• NP461019.RAk6cJMxFV91LYL0YncALP2x7nP0_aFs3jqCZQkbpuiYA130_assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP461019.RAk6cJMxFV91LYL0YncALP2x7nP0_aFs3jqCZQkbpuiYA130_provenance.
• assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP250128.RAXVRWO0lHSSlPzZkOGjdDm683KKZNB51gwVNaBXBvIdw130_assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP250128.RAXVRWO0lHSSlPzZkOGjdDm683KKZNB51gwVNaBXBvIdw130_provenance.
• NP387828.RAYuUqTVli6zNUU8gyqoSzXGyGJu1zAb4_nzG0qiMtJ4Y130_assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP387828.RAYuUqTVli6zNUU8gyqoSzXGyGJu1zAb4_nzG0qiMtJ4Y130_provenance.
• assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1300616.RAaUC45TvA8q2I_ur0hA49HPpcRKQKHDRYy8bXXAOC7cQ130_assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1300616.RAaUC45TvA8q2I_ur0hA49HPpcRKQKHDRYy8bXXAOC7cQ130_provenance.
• NP1300611.RAoUcl0wOKPlD9oEPLtvod9emvozzGEuXD4nWW0D95LD4130_assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1300611.RAoUcl0wOKPlD9oEPLtvod9emvozzGEuXD4nWW0D95LD4130_provenance.
• NP1300613.RAv8Tj_1Xj2rAGoHR1t6-t_zk-InZWPSn8hd2_RYTVKn4130_assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1300613.RAv8Tj_1Xj2rAGoHR1t6-t_zk-InZWPSn8hd2_RYTVKn4130_provenance.
• NP251121.RALKZv_eYlQ__rlH6iS6VUdpJVVx-urh8oJTT1uOTG6Ds130_assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP251121.RALKZv_eYlQ__rlH6iS6VUdpJVVx-urh8oJTT1uOTG6Ds130_provenance.
• NP577130.RA0a3W9-ThwdCeGcPvtGNHShbCW6Zy8xBLLQKehLqOXeI130_assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP577130.RA0a3W9-ThwdCeGcPvtGNHShbCW6Zy8xBLLQKehLqOXeI130_provenance.
• NP1300608.RAEs0ESsQ0xIDSAZ_lxhmTmlqf2dAv7y62FthAB3bS-hY130_assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1300608.RAEs0ESsQ0xIDSAZ_lxhmTmlqf2dAv7y62FthAB3bS-hY130_provenance.
• NP1300617.RAPv1UI8TadsFiQh0lg7bxg2LvQed3Pob5LYr6SEVit0w130_assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1300617.RAPv1UI8TadsFiQh0lg7bxg2LvQed3Pob5LYr6SEVit0w130_provenance.
• NP1300619.RALNpaWBotrCFnnb688_uLS05ABYY5DcXo9Ingz4SQ1fg130_assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1300619.RALNpaWBotrCFnnb688_uLS05ABYY5DcXo9Ingz4SQ1fg130_provenance.
• NP1300610.RAxQGVpOgvGajMznzQRJ9LUADIa_EevxEjnOZQfFUZRkw130_assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1300610.RAxQGVpOgvGajMznzQRJ9LUADIa_EevxEjnOZQfFUZRkw130_provenance.
• NP1300618.RA4bFuaYDEjdXvZ-SzwMWGjwC82aDYOfUBg73qQFrQ56g130_assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1300618.RA4bFuaYDEjdXvZ-SzwMWGjwC82aDYOfUBg73qQFrQ56g130_provenance.